|
Laxman Pai, Opalesque Asia: Private equity, venture capital, and hedge funds so far this year have poured $60.72 billion into healthcare companies, said a study.
According to a report from S&P Global, healthcare raised $22.44 billion through private equity and venture capital deals in the third quarter, indicating strong investor interest in the industry amid the uncertain COVID-19 situation.
The gross value of these investments, which include M&A deals where the buyer was private equity or venture capital firm or a hedge fund manager, was up 17.4% on an annual basis, according to S&P Global Market Intelligence data.
This is the third-highest total for the healthcare industry during a single quarter since 2016. Investments peaked in the second quarter of 2018, with 701 deals bringing in $38.68 billion.
"The aggregate transaction value for the healthcare industry in 2020 was $60.72 billion based on 2,072 deals tracked by S&P Global Market Intelligence. Only industrials and information technology attracted more investment and raised $65.05 billion and $97.50 billion, respectively," explained the report.
Biotechnology, which had the highest investment activity among healthcare subsectors in the first half of the year, held onto its lead and brought in about one-third of the total investment pool in 2020. Biotech businesses garnered $20.19 billion in investments based on 577 deals announced between Jan. 1 and Sept. 30.
Healthcare technology also saw...................... To view our full article Click here
|
RSS
